|
|
|
 |
FDA Approval Activities for this Drug…
BICALUTAMIDE Tablet; 50MG CASODEX ASTRAZENECA | CASODEX (bicalutamide) Tablets, AstraZeneca Pharma, Labeling Revision | CASODEX (bicalutamide) tablets, AstraZeneca Pharma, Labeling Revision | Bicalutamide Tablets, Sandoz Inc., Tentative Approval | Bicalutamide Tablets, Accord Healthcare Inc., USA, Tentative Approval | Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals LP, Approval | Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals, LP, Labeling Revision | Bicalutamide Tablets, Accord Healthcare Inc., Approval | Bicalutamide Tablets, KUDCO Ireland, Ltd., Approval | Bicalutamide Tablets, Mylan Pharmaceuticals Inc., Approval | Bicalutamide Tablets, Sandoz, Inc., Approval | Bicalutamide Tablets, Sun Pharma Global Inc., Approval | Bicalutamide Tablets, Synthon Pharmaceuticals, Inc., Approval | Bicalutamide Tablets, TEVA Pharmaceuticals, Approval | Bicalutamide Tablets, Zydus Pharmaceuticals USA Inc., Approval | Bicalutamide Tablets, Actavis Totowa LLC, Approval | Bicalutamide Tablets, Fresenius Kabi Oncology, Approval | Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision | Bicalutamide Tablets, Roxane Laboratories, Inc., Approval
  
|